ADD CONDITION

items per page

Fleet

Last content change checked dailysee data sync status

Active ingredient
Glycerin 2 g
Other brand names
Dosage form
Suppository
Route
Rectal
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2025
Label revision date
October 30, 2025
Active ingredient
Glycerin 2 g
Other brand names
Dosage form
Suppository
Route
Rectal
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2025
Label revision date
October 30, 2025
Manufacturer
C. B. Fleet Company, Inc.
NDC root
0132-0090

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Fleet® Glycerin is a type of laxative that comes in the form of suppositories. It is designed to provide relief from occasional constipation, helping to stimulate a bowel movement typically within 15 minutes to 1 hour after use.

Each package contains 24 adult suppositories, making it a convenient option for those seeking quick relief from discomfort associated with constipation.

Uses

If you're experiencing occasional constipation, this product can help provide relief. It typically works quickly, usually prompting a bowel movement within 15 minutes to 1 hour after taking it. This makes it a convenient option when you need fast relief from discomfort.

Dosage and Administration

When using this medication, you will typically take one suppository once a day if you are an adult or a child aged 6 years and older. If your child is between 2 and 6 years old, it's best to use Fleet® Pedia-Lax®™ Suppositories. For children under 2 years, please consult a doctor before use.

To use the suppository, you should insert it well into the rectum (the opening at the end of the digestive tract) to help it work effectively as a laxative (a substance that helps relieve constipation). Keep in mind that the suppository is designed to dissolve only partially, so you may not notice it completely melting away.

What to Avoid

You should avoid using laxative products if you are experiencing abdominal pain, nausea, or vomiting unless your doctor has specifically instructed you to do so. It's important to stop using the product and consult your doctor if you notice rectal bleeding or if you do not have a bowel movement within one hour of using it.

Additionally, you should ask your doctor before using any laxative if you have experienced a sudden change in your bowel habits that lasts more than two weeks or if you have already been using a laxative for more than one week. Taking these precautions can help ensure your safety and well-being.

Side Effects

When using this product, you may experience some rectal discomfort or a burning sensation. It's important to stop using it and consult a doctor if you notice any rectal bleeding or if you do not have a bowel movement within one hour of use, as these could be signs of a more serious condition.

Please remember that this product is for rectal use only. Avoid using laxative products if you have abdominal pain, nausea, or vomiting unless directed by a doctor. Keep this product out of reach of children, and if swallowed, seek medical help or contact a Poison Control Center immediately.

Warnings and Precautions

This product is intended for rectal use only. It's important not to use laxative products if you are experiencing abdominal pain, nausea, or vomiting unless your doctor has specifically advised you to do so. Before using any laxative, consult your doctor if you have noticed a sudden change in your bowel habits lasting more than two weeks or if you have already been using a laxative for more than one week.

While using this product, you may experience some rectal discomfort or a burning sensation. If you notice rectal bleeding, do not have a bowel movement within one hour of use, or experience any other concerning symptoms, stop using the product and contact your doctor, as these could indicate a serious condition. Always keep this product out of reach of children, and if it is swallowed, seek medical help or contact a Poison Control Center immediately.

Overdose

If you or someone else has swallowed too much of a medication, it’s important to seek medical help immediately. You can do this by contacting a Poison Control Center or going to the nearest emergency room. Acting quickly can make a significant difference in the outcome.

Signs of an overdose can vary, but they may include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these symptoms, don’t hesitate to get help right away. Remember, it’s always better to be safe and get checked by a healthcare professional.

Pregnancy Use

When it comes to using this product during pregnancy, there is no specific information available about its safety or potential risks to you or your developing baby. The insert does not indicate whether the product is contraindicated (not recommended) for pregnant individuals, nor does it mention any necessary dosage changes or special precautions for use during pregnancy.

If you are pregnant or planning to become pregnant, it’s always best to consult with your healthcare provider before using any medication or product to ensure it’s safe for you and your baby.

Lactation Use

If you are breastfeeding or planning to breastfeed, it's important to consult your doctor before using this product. There is a possibility that it may be excreted in breast milk, which means it could potentially affect your baby. Since the effects on nursing infants have not been thoroughly studied, exercising caution is recommended. Always prioritize your health and your baby's well-being by discussing any concerns with your healthcare provider.

Pediatric Use

When it comes to using Fleet® Pedia-Lax®™ Suppositories for children, it's important to follow specific guidelines. For children aged 2 to under 6 years, you can safely use these suppositories. However, if your child is under 2 years old, it's essential to consult a doctor before use to ensure their safety.

For older children, specifically those 6 years and older, the recommended dosage is one suppository or as directed by a healthcare professional. Always make sure to follow these age-specific recommendations to ensure the best care for your child.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the insert does not provide special monitoring or safety considerations tailored for patients with renal impairment (kidney issues).

Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment plan.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication should be used if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your liver health. They can help determine the best course of action based on your individual situation.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you. Always share your complete list of medications and any recent lab tests to avoid any potential issues. Your health and safety should always come first.

Storage and Handling

To ensure the safety and effectiveness of your product, always store the container tightly closed and keep it away from excessive heat. This helps maintain its quality and prevents any potential degradation.

Before using the product, check that the mouth of the jar is sealed properly. If the foil with the green Fleet® emblem is missing or torn, do not use the product, as this indicates it may not be safe. Following these guidelines will help you handle the product safely and effectively.

Additional Information

No further information is available.

FAQ

What is Fleet® Glycerin used for?

Fleet® Glycerin is a laxative suppository used for the relief of occasional constipation.

How quickly does Fleet® Glycerin work?

This product usually produces a bowel movement in ¼ to 1 hour.

What is the recommended dosage for adults and children over 6 years?

Adults and children 6 years and over should use 1 suppository or as directed by a doctor.

What should I do if I experience rectal bleeding?

You should stop using this product and consult a doctor if you have rectal bleeding.

Can I use Fleet® Glycerin if I have abdominal pain or nausea?

No, you should not use laxative products when abdominal pain, nausea, or vomiting are present unless directed by a doctor.

Is Fleet® Glycerin safe for children under 2 years?

Children under 2 years should consult a doctor before using Fleet® Glycerin.

What should nursing mothers do before using this product?

Nursing mothers should consult a doctor before using Fleet® Glycerin, as there is a potential for excretion in breast milk.

How should I store Fleet® Glycerin?

Store the container tightly closed and keep it away from excessive heat.

What should I do if I don't have a bowel movement within 1 hour of using this product?

If you do not have a bowel movement within 1 hour, stop using the product and consult a doctor, as this may indicate a serious condition.

Packaging Info

Below are the non-prescription pack sizes of Fleet (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Fleet.
Details

Drug Information (PDF)

This file contains official product information for Fleet, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the relief of occasional constipation. It typically produces a bowel movement within 15 minutes to 1 hour after administration.

There are no teratogenic or nonteratogenic effects associated with this product.

Dosage and Administration

For adults and children aged 6 years and older, the recommended dosage is one suppository per 24 hours, or as directed by a healthcare professional. For children aged 2 to under 6 years, Fleet® Pedia-Lax®™ Suppositories should be utilized. In the case of children under 2 years, it is advised to consult a doctor prior to administration.

The suppository should be inserted well up into the rectum to ensure effective laxative action. It is important to note that the suppository is designed to dissolve only partially, which may not be visibly apparent during use.

Contraindications

Laxative products are contraindicated in patients experiencing abdominal pain, nausea, or vomiting unless directed by a healthcare professional.

The use of this product should be discontinued and a physician consulted if rectal bleeding occurs or if there is no bowel movement within 1 hour of administration.

Additionally, patients should seek medical advice prior to using any laxative if they have experienced a sudden change in bowel habits lasting more than 2 weeks or if they have been using a laxative for more than 1 week.

Warnings and Precautions

For rectal use only. It is imperative that laxative products are not utilized in the presence of abdominal pain, nausea, or vomiting unless specifically directed by a healthcare professional.

Healthcare providers should advise patients to seek medical consultation prior to using any laxative if they experience a sudden change in bowel habits lasting more than two weeks or if they have been using a laxative for more than one week.

During the use of this product, patients may experience rectal discomfort or a burning sensation. Should any of the following occur, it is crucial to discontinue use and consult a healthcare provider immediately: rectal bleeding, failure to achieve a bowel movement within one hour of administration, or any other concerning symptoms, as these may indicate a serious underlying condition.

This product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients using this product may experience certain adverse reactions. Commonly reported reactions include rectal discomfort or a burning sensation.

Serious adverse reactions warrant immediate medical attention. Patients should discontinue use and consult a doctor if they experience rectal bleeding or if there is no bowel movement within one hour of administration, as these symptoms may indicate a serious underlying condition.

It is important to note that this product is intended for rectal use only. Laxative products should not be used in the presence of abdominal pain, nausea, or vomiting unless directed by a healthcare professional.

Additionally, this product should be kept out of reach of children. In the event of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Fleet (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Fleet.
Details

Pediatric Use

Pediatric patients aged 2 to under 6 years may use Fleet® Pedia-Lax®™ Suppositories as directed. For children under 2 years, it is advised to consult a doctor prior to use. In patients aged 6 years and older, the recommended dosage is 1 suppository or as directed by a healthcare professional.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The available prescribing information does not provide specific data regarding the use of this product during pregnancy. There are no contraindications noted for pregnant patients, nor are there any associated risks to the fetus identified in the available literature. Additionally, no dosage modifications or special precautions for use during pregnancy have been specified. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

Lactating mothers should consult a doctor before using this product. There is a potential for excretion in breast milk, and the effects on nursing infants are not well studied; therefore, caution is advised.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are vital to ensure patient safety and effective recovery.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use laxative products if they are experiencing abdominal pain, nausea, or vomiting unless directed by a healthcare professional. It is important to counsel patients to stop using the product and consult a doctor if they experience rectal bleeding or if they do not have a bowel movement within one hour of using the product, as these symptoms may indicate a serious condition.

While using this product, patients may experience rectal discomfort or a burning sensation. Healthcare providers should encourage patients to ask a doctor before using any laxative if they have had a sudden change in bowel habits lasting more than two weeks or if they have already used a laxative for more than one week.

Storage and Handling

The product is supplied in a container that must be stored tightly closed to maintain its integrity. It is essential to keep the container away from excessive heat to ensure optimal preservation of the product. The mouth of the jar is sealed for safety; therefore, if the foil imprinted with the green Fleet® emblem is missing or torn, the product should not be used.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Fleet, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Fleet, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.